During the past decade, University Hospital in Krakow conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital in Krakow" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Biotronik AG" with 1 trials sponsored, "BrainsGate" with 1 trials sponsored and "CTI BioPharma" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital in Krakow" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Cardialysis B.V." with 1 trials as a collaborator, "European Cardiovascular Research Center" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital in Krakow" are "Coronary Artery Disease" (5 trials), "Cardiovascular Disease" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "University Hospital in Krakow" in a lesser frequency.

Most popular intervention types in "University Hospital in Krakow" are "Drug" (7 trials), "Device" (5 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "12 months DAPT" (1 trials), "6 months DAPT" (1 trials) and "ABSORB BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital in Krakow" are 15 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital in Krakow". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Hospital in Krakow, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital in Krakow, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".